Rchr
J-GLOBAL ID:200901070248210849
Update date: Feb. 23, 2025 Kazuhiko Nakagawa
ナカガワ カズヒコ | Kazuhiko Nakagawa
Affiliation and department: Job title:
Professor
Research field (1):
Respiratory medicine
Research keywords (2):
臨床腫瘍学
, Medical Oncology
Research theme for competitive and other funds (12): - 2014 - 2017 A biomarker study of heregulin to predict efficacy of anti-HER2 drugs in HER2-positive breast and gastric cancer
- 2012 - 2015 Antitumor Action of the MET Tyrosine Kinase Inhibitor in Gastric Cancer Positive for MET Amplification
- 2012 - 2015 Multiplex molecular profiling in advanced non-small cell lung cancers
- 2011 - 2013 Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations.
- 2011 - 2011 EML4-ALK陽性肺癌におけるシグナル伝達経路の解析
- 2009 - 2011 Molecular-based approach for overcoming acquired resistance to EGFR tyrosine kinase inhibitors
- 2005 - 2007 Translational research for recurrent lung cancer treatment with combination therapy of gefitinib and meloxicam
- 2004 - 2006 A randomized study to evaluate survival benefit of gefitinib in patients with advanced non-small cell lung cancer and correlation of efficacy and biomarkers
- 肺癌化学療法の確立
- 新しい抗癌剤の臨床開発
- Establishment of Lung cancer chemotherapy
- Clinical developement of new anti-cancer drugs
Show all
Papers (1,369): -
Kazuo Nakagawa, Shun-Ichi Watanabe, Masashi Wakabayashi, Masaya Yotsukura, Takahiro Mimae, Aritoshi Hattori, Tomohiro Miyoshi, Mitsuhiro Isaka, Makoto Endo, Hiroshige Yoshioka, et al. Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025. 20. 2. 157-166
-
Kazuo Nakagawa, Shun-Ichi Watanabe, Masashi Wakabayashi, Yuta Sekino. A Response to Letter to the Editor: "Refining Risk Stratification for Locoregional Relapse in Clinical Stage IA Small-Sized Peripheral NSCLC After Segmentectomy". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025. 20. 2. e22-e23
-
Kazuo Nakagawa, Shun-Ichi Watanabe, Masashi Wakabayashi, Yuta Sekino. A Response to the Letter to the Editor: "Sites of Primary Tumors as Crucial Points When Conducting Segmentectomy for NSCLC". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025. 20. 2. e24-e25
-
Kazuo Nakagawa, Shun-Ichi Watanabe, Masashi Wakabayashi, Yuta Sekino. A Response to Letter to the Editor: "Considerations on Genetics and Treatment Factors in NSCLC Segmentectomy Outcomes". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025. 20. 2. e27-e28
-
Naoki Shiraishi, Takayuki Takahama, Kazuko Sakai, Kaoru Tanaka, Yuzuki Nakagawa, Hiroaki Kanemura, Tomohiro Nakayama, Yusuke Kawanaka, Takashi Kurosaki, Shinichiro Suzuki, et al. Detection of Overlooked Rare EGFR Mutations in Non-small Cell Lung Cancer Using Multigene Testing. Thoracic cancer. 2025. 16. 3. e70007
more... MISC (1,092): -
小田いつき, 小田いつき, 池川敦子, 池川敦子, 田村和朗, 田村和朗, 三谷誠一郎, 佐藤華子, 松井繁長, 稲垣千晶, et al. Multi-Gene Panel Testing(MGPT)を行った4症例の遺伝カウンセリングの経験. 日本遺伝性腫瘍学会学術集会プログラム・抄録集. 2024. 30th
-
庄田 浩康, 池田 慧, 坪井 正博, 坂井 和子, 三角 俊裕, 赤松 弘朗, 棚橋 雅幸, 丹保 裕一, 齋藤 春洋, 豊岡 伸一, et al. 完全切除後II-III期のEGFR変異陽性非小細胞肺癌に対する第III相IMPACT試験における付随バイオマーカー研究. 肺癌. 2023. 63. 5. 499-499
-
金村 宙昌, 竹原 俊幸, 小野寺 勇太, 寺村 岳士, 鈴木 慎一郎, 坂井 和子, 西尾 和人, 中川 和彦, 林 秀敏, 米阪 仁雄. PTPRRを介したEGFR活性化に起因するKRASG12C阻害薬耐性の克服(Combating acquired resistance to KRAS inhibitors in NSCLC by targeting PTPRR-mediated activation of EGFR signaling). 日本癌学会総会記事. 2023. 82回. 422-422
-
阪本亮, 阪本亮, 松岡弘道, 鶴谷純司, 千葉康敬, 藤田至彦, 酒井清裕, 吉田健史, 吉田健史, 名倉美樹, et al. Comparing morphine with oxycodone for cancer pain using a catechol-O-methyltransferase genotype biomarker (RELIEF study): A randomized clinical trial. 日本心身医学会総会ならびに学術講演会抄録集. 2023. 64th
-
米阪仁雄, 稲垣千昌, 稲垣千昌, 高濱隆幸, 高濱隆幸, 白石直樹, 磯本晃佑, 金村宙昌, 鈴木慎一郎, 谷崎潤子, et al. Providing Anti-Lung Cancer Drug Therapy Based on Genetic Information by Comprehensive Genomic Profiling. 日本癌学会学術総会抄録集(Web). 2023. 82nd
more... Patents (1): Books (1): Lectures and oral presentations (862): -
WJOGの現状と今後の展望
(第94回日本胃癌学会総会 2022)
-
Distinctive characteristics MSI-H in chemo;immune therapy for gastric cancer
(2022)
-
FOLRα positive gastric cancer exhibits chemorisistance that is overcome by a novel ADC,MoRAb-202
(2022)
-
Genomic and Transcriptomic Features of Response to Immune Checkpoint Inhibitors in Small Cell Lung Cancer
(第19回日本臨床腫瘍学会学術集会 2022)
-
Primary Data;from DESTINY-Lun;A Phase;Trial of Trastuzumab Deruxtecan in HE;Mutated Metastatic NSCLC
(第19回日本臨床腫瘍学会学術集会 2022)
more... Education (2): - - 1983 Kumamoto University School of Medicine
- - 1983 Kumamoto University Faculty of Medicine
Professional career (1): - PhD (Medicine) (Kumamoto University)
Committee career (6): - 2015/04 - 現在 西日本胸部臨床腫瘍臨床研究機構(WJTOG) 理事長
- 2009/01 - 現在 日本臨床薬理学会 指導医
- 2006/05 - 現在 日本呼吸器学会 代議員
- 2004/04 - 現在 日本臨床腫瘍学会 協議員、副理事長(2013年~2019年)、理事(2008年~2022年)、暫定指導医(2004年~2019)、学術企画委員会(2013年~2022年)
- 2000/10 - 現在 日本肺癌学会 理事(2006年~)、評議員及び財務委員(2014年~)
- 日本内科学会 近畿支部・評議員
Show all
Awards (3): - 1997 - 米国臨床腫瘍学会トラベルアワード(ASCO)
- 1996 - 米国癌学会トラベルアワード(AACR)
- 1988 - 米国臨床腫瘍学会トラベルアワード(ASCO)
Association Membership(s) (12):
西日本胸部臨床腫瘍臨床研究機構(WJTOG)
, がん分子標的治療研究会
, 欧州癌治療学会(ESMO)
, 日本呼吸器内視鏡学会
, 日本臨床腫瘍学会
, 日本呼吸器学会
, 日本癌治療学会
, 世界肺癌学会(IASLC/WCLC)
, 米国臨床腫瘍学会(ASCO)
, 日本内科学会
, 日本癌学会
, 日本肺癌学会
Return to Previous Page